NEI Research News

At the suggestion of a National Eye Institute employee who is deaf, NIH recently amended its official mission statement.

Anthony Movshon, Ph.D., an NEI grantee and director of New York University’s Center for Neural Science, has won the 2013 Karl Spencer Lashley Award from the American Philosophical Society (APS).

Stephen J. Ryan, M.D., highly regarded for his leadership and tireless advocacy on behalf of the NEI, passed away April 29, 2013.

Three researchers supported in part by NEI have been elected to the National Academy of Sciences, a nonprofit organization that advises the U.S. government on matters of science and technology.

Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans.

Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans.

An international group of researchers has discovered seven new regions of the human genome—called loci-that are associated with increased risk of age-related macular degeneration (AMD), a leading cause of blindness.

Edward S. Boyden, Ph.D., a neuroscientist and NEI grantee at the Massachusetts Institute of Technology in Boston, has been honored with a 2013 Brain Prize.

On February 14, 2013, the U.S. Food and Drug Administration approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

In 2008, a team of scientists funded by the National Eye Institute (NEI), a part of the National Institutes of Health, reported major progress in the treatment of an inherited form of progressive blindness using gene therapy.